日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trials

用于胶质母细胞瘤治疗的肿瘤抗原(TAO)疫苗平台:临床试验证据的系统评价

Chen, Hsien-Chung; Wong, Eric T; Sarangi, Sasmit; Elinzano, Heinrich; Kuburich, Nick A; Mani, Sendurai A; Ali, Rohaid; Cielo, Deus; Svokos, Konstantina A; Sampath, Prakash; Malik, Athar N; Lee, Christine K; Doberstein, Curtis E; Lawler, Sean E; Seyhan, Attila; El-Deiry, Wafik S; Chen, Clark C

Corrigendum to "P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9" [Neoplasia, volume 23 (2021) 304325]

对“通过 ERK1/2 和 CDK9 对 ATF4 转录的调控,在 p53 突变的肿瘤中实现 p53 通路的 P53 非依赖性部分恢复”的更正 [Neoplasia,第 23 卷(2021 年)304325]

Tian, Xiaobing; Ahsan, Nagib; Lulla, Amriti; Lev, Avital; Abbosh, Philip; Dicker, David T; Zhang, Shengliang; El-Deiry, Wafik S

miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma.

miR-181d 协调胶质母细胞瘤中的同源重组和抗肿瘤免疫反应。

Singh Gatikrushna, Singh Shilpi, Mohapatra Iteeshree, Hou Jay, Ni Andrew, Barik Debashis, Zheng Haoyi, Kim Stefan, Sharma Mayur, Lawler Sean, Vasudevan Shobha, Kokkoli Efrosini, Sarangi Sasmit, Elinzano Heinrich, Wong Eric T, Martinez-Moreno Margot, Gokaslan Ziya, El-Deiry Wafik, Chen Clark C

PIM1 expression is prognostic in clear cell renal cell carcinoma and influenced by an IL-6/JAK/STAT axis.

PIM1 表达是透明细胞肾细胞癌的预后指标,并受 IL-6/JAK/STAT 轴的影响。

Meza Kimberly S, Seymour Kimberly, Eteshola Elias Ou, Payne Natalie, Rodriguez Brianna, Graff Stephanie L, Smith Norm, Elliott Andrew, El-Deiry Wafik S, Holder Sheldon L

COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms

新冠疫苗接种与感染后癌症信号:评估模式和潜在生物学机制

Kuperwasser, Charlotte; El-Deiry, Wafik S

Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53

假设:HPV E6 和 COVID 刺突蛋白协同作用,通过 p53 靶向抑制肿瘤生长

El-Deiry, Wafik S

XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance

XPO1 R749Q 突变与 POLE 突变在癌症中同时发生,可作为克服化疗耐药性的靶点。

Totiger, Tulasigeri M; Chiraphapphaiboon, Wannasiri; Baca, Yasmine; Chaudhry, Sana; Notti, Ryan Q; Montoya, Skye; Chojnacka, Monika; Gaidosh, Gabriel; Afaghani, Jumana; Affer, Maurizio; Armstrong, Christopher; Kavanaugh, Paul M; Karaca, Efe; Zabroski, Jenna; Lewis, Michael; Maye, Alyssa; Jahn, Jacob; Soni, Rajesh K; Bilbao, Daniel; Walker, Phil; Elliott, Andrew; Lou, Emil; El-Deiry, Wafik S; Rodriguez, Jose Antonio; Nguyen, Hai Dang; Taylor, Justin

Corrigendum to Targeting apoptotic pathways for cancer therapy

关于“靶向细胞凋亡通路进行癌症治疗”一文的更正

Tian, Xiaobing; Srinivasan, Praveen R; Tajiknia, Vida; Sanchez Sevilla Uruchurtu, Ashley F; Seyhan, Attila A; Carneiro, Benedito A; De La Cruz, Arielle; Pinho-Schwermann, Maximilian; George, Andrew; Zhao, Shuai; Strandberg, Jillian; Di Cristofano, Francesca; Zhang, Shengliang; Zhou, Lanlan; Raufi, Alexander G; Navaraj, Arunasalam; Zhang, Yiqun; Verovkina, Nataliia; Ghandali, Maryam; Ryspayeva, Dinara; El-Deiry, Wafik S

The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer

前列腺癌治疗中抗体药物偶联物(ADC)的演变格局

Lin, Claire; Hadfield, Matthew J; Santopietro, Ariana; Lagos, Galina; Cheng, Liang; El-Deiry, Wafik S; Aggarwal, Rahul; Mega, Anthony; Hyams, Elias; Carneiro, Benedito A

Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance.

前馈 miR-181d 降解调节甲基鸟嘌呤甲基转移酶和替莫唑胺耐药性的群体变异。

Singh Gatikrushna, Singh Shilpi, Mohapatra Iteeshree, Kim Stefan, Sharma Mayur, Akers Johnny, Nguyen Thien, Wong Eric, Moreno Margot Martinez, Kokkoli Efrosini, Vasudevan Shobha, Lawler Sean E, El-Deiry Wafik S, Gokaslan Ziya, Chen Clark C